Lori Mc Neill Sonnet Bio Therapeutics Holdings, Inc. (SONN) insider trading activity

SONN Quotes by TradingView

Lori Mc Neill is Director of Sonnet BioTherapeutics Holdings, Inc.. Currently has a direct ownership of 4,394 shares of SONN, which is worth approximately $19,904. The most recent transaction as insider was on Jul 11, 2025, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.39K
1015.23% 3M change
1015.23% 12M change
Total Value Held $19,904

Lori McNeill Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 11 2025
BUY
Grant, award, or other acquisition
-
4,000 Added 47.65%
4,394 Common Stock
Dec 11 2023
BUY
Grant, award, or other acquisition
-
373 Added 48.63%
394 Common Stock
Dec 14 2022
BUY
Grant, award, or other acquisition
-
3,770 Added 50.0%
3,770 Common Stock
LM

Lori Mc Neill

Director
Princeton,, NJ

Track Institutional and Insider Activities on SONN

Follow Sonnet BioTherapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SONN shares.

Notify only if

Insider Trading

Get notified when an Sonnet Bio Therapeutics Holdings, Inc. insider buys or sells SONN shares.

Notify only if

News

Receive news related to Sonnet BioTherapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SONN